Evidence map›Paper›PMID 16861626›Full record

Trial reportInfection and immunity2006

Filaria-induced monocyte dysfunction and its reversal following treatment.

Roshanak Tolouei Semnani, Paul B Keiser, Yaya I Coulibaly, Falaye Keita, Abdallah A Diallo, Diakaridia Traore, Dapa A Diallo, Ogobara K Doumbo, Sekou F Traore, Joseph Kubofcik and 2 more

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Infection and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Association of aThe American journal of tropical medicine and hygiene · 2019
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Roshanak Tolouei SemnaniHelminth Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, 4 Center Drive, Room 4/126, National Institutes of Health, Bethesda, Maryland 20892, USA. rsemnani@niaid.nih.gov
Paul B Keiser
Yaya I Coulibaly
Falaye Keita
Abdallah A Diallo
Diakaridia Traore
Dapa A Diallo
Ogobara K Doumbo
Sekou F Traore
Joseph Kubofcik
Amy D Klion
Thomas B Nutman
University of Bamako · MLNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic InfectionZIAAI000197 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$23.4M
Immunoregulation /Recognition In non/filarial InfectionZ01AI000197 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI NUTMAN, THOMAS B. · 1985 to 2008
$3.5M
Intramural NIH HHS
6 · The paper itself

Abstract

Monocyte dysfunction in filarial infection has been proposed as one mechanism underlying the diminished antigen-specific T-cell response seen in patent lymphatic filariasis. Cytokine/chemokine production and gene expression in monocytes from filaria-infected patients and uninfected healthy donors were assessed unstimulated and in response to stimulation with Staphylococcus aureus Cowan I bacteria plus gamma interferon both before and 8 months following treatment. Monocytes from filaria-infected individuals were studded with intracellular microfilarial antigens. Furthermore, monocytes from these individuals were less capable of producing interleukin-8 (IL-8), Exodus II, MIP-1alpha, MIP-1beta, and IL-1alpha and preferentially expressed genes involved in apoptosis and adhesion compared with monocytes from uninfected donors. Eight months following treatment with a single dose of ivermectin-albendazole, some of these defects were reversed, with monocyte production of IL-8, IL-1alpha, MIP-1alpha, and IL-10 being comparable to that seen in the uninfected controls. In addition, a marked increase in mRNA expression of genes associated with protein metabolism, particularly heat shock proteins, was seen compared with pretreatment expression. These data suggest that the function and gene expression of monocytes in filaria-infected patients are altered but that this dysfunction is partially reversible following antifilarial treatment.

Indexed as

Elephantiasis, FilarialAlbendazoleAnimalsAnthelminticsAntiparasitic AgentsDrug Therapy, CombinationGene ExpressionHeat-Shock ProteinsHumansIvermectinMolecular Sequence DataMonocytesTreatment OutcomeWuchereria bancroftiAlbendazoleAnthelminticsAntiparasitic AgentsHeat-Shock ProteinsIvermectin

Identifiers

PMID16861626
PMCPMC1539612
OpenAlexW2111229343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.